Japan Society of Obstetrics and Gynecology Gynecologic Tumor Committee: Survey on Fertility-Sparing Treatment for Early stage Endometrial Cancer in Japan

Japan Society of Obstetrics and Gynecology Gynecologic Tumor Committee: Survey on Fertility-Sparing Treatment for Early stage Endometrial Cancer in Japan - Survey on Fertility-Sparing Treatment for Endometrial Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034254

Enrollment

270

Registered

2018-09-26

Start date

2018-08-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Endometrial cancer patients who received fertility - sparing treated by the Japanese hospitals joining to the JSOG tumor committee and agreed to join this study.

Exclusion criteria

Exclusion criteria: Patients who has no indication of fertility sparing treatment. Patients who were already treated by the other hospitals.

Design outcomes

Primary

Measure	Time frame
National data of complete response rate of the end of fertility-sparing treatment	—

Secondary

Measure	Time frame
Frequency and grade of adverse event of the treatment, number of pregnancy and obstetrical prognosis after treatment	—

Countries

Japan

Contacts

Public ContactKimio Ushijima

Kurume University School of Medicine Department of Obstetrics and Gynecology Department of Obstetrics and Gynecology

kimi@med.kurume-u.ac.jp0942317573

Outcome results